相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiorespiratory adaptation during 6-Minute Walk Test in fibrotic idiopathic interstitial pneumonia patients who did or did not respond to pulmonary rehabilitation
Baptiste Chehere et al.
EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE (2019)
Lessons from negative dyspnoea studies: arguments for the multidimensional evaluation of multidirectional therapeutic approaches
Thomas Similowski et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Holistic services for people with advanced disease and chronic breathlessness: a systematic review and meta-analysis
Lisa Jane Brighton et al.
THORAX (2019)
Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis
Prosenjit Dutta et al.
THORAX (2019)
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label mixed-method, crossover randomised controlled trial
Dina Visca et al.
LANCET RESPIRATORY MEDICINE (2018)
Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study
Sabrina Bajwah et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Patient and partner empowerment programme for idiopathic pulmonary fibrosis
Mirjam J. G. van Manen et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Effects of hyperoxia on dyspnoea and exercise endurance in fibrotic interstitial lung disease
Michele R. Schaeffer et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial
Leona M. Dowman et al.
THORAX (2017)
BTS guideline for oxygen use in adults in healthcare and emergency settings
B. R. O'Driscoll et al.
THORAX (2017)
Palliative care in interstitial lung disease: living well
Michael Kreuter et al.
LANCET RESPIRATORY MEDICINE (2017)
A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial
Surinder S. Birring et al.
LANCET RESPIRATORY MEDICINE (2017)
Benefits of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
Nathalie Torres Del Castillo et al.
CHEST (2017)
Common Mechanisms of Dyspnea in Chronic Interstitial and Obstructive Lung Disorders
Azmy Faisal et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Short-Term Improvement in Physical Activity and Body Composition After Supervised Exercise Training Program in Idiopathic Pulmonary Fibrosis
Baruch Vainshelboim et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2016)
Effect of long-term treatment with corticosteroids on skeletal muscle strength, functional exercise capacity and health status in patients with interstitial lung disease
Masatoshi Hanada et al.
RESPIROLOGY (2016)
LATE-BREAKING ABSTRACT: Significant improvement in refractory chronic cough with inhaled PA101 in patients with idiopathic pulmonary fibrosis: Results from phase 2 trial
Surinder Birring et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Effects of a 3-week pulmonary rehabilitation program in patients with idiopathic pulmonary fibrosis - A randomized, controlled trial
Inga Jarosch et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Idiopathic pulmonary fibrosis and cancer: do they really look similar?
Carlo Vancheri
BMC MEDICINE (2015)
The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation
[Anonymous]
HEALTH TECHNOLOGY ASSESSMENT (2015)
Cardiorespiratory Function Before and After Aerobic Exercise Training in Patients With Interstitial Lung Disease
Randall E. Keyser et al.
JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION (2015)
Long-Term Effects of a 12-Week Exercise Training Program on Clinical Outcomes in Idiopathic Pulmonary Fibrosis
Baruch Vainshelboim et al.
LUNG (2015)
Changes in fatigability following intense aerobic exercise training in patients with interstitial lung disease
Randall E. Keyser et al.
RESPIRATORY MEDICINE (2015)
A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER STUDY TO ASSESS THE EFFICACY OF A SINGLE DOSE OF 100 MG OF VRP700 BY INHALATION IN REDUCING THE FREQUENCY AND SEVERITY OF COUGH IN ADULT PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
I. Satia et al.
THORAX (2015)
Palliative care for patients with advanced fibrotic lung disease: a randomised controlled phase II and feasibility trial of a community case conference intervention
Sabrina Bajwah et al.
THORAX (2015)
Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach
Spyros A. Papiris et al.
BMC PULMONARY MEDICINE (2015)
Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia
Tamera J. Corte et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Exercise Limitation in IPF Patients: A Randomized Trial of Pulmonary Rehabilitation
Robert M. Jackson et al.
LUNG (2014)
Exercise Training-Based Pulmonary Rehabilitation Program Is Clinically Beneficial for Idiopathic Pulmonary Fibrosis
Baruch Vainshelboim et al.
RESPIRATION (2014)
Endurance Time Is the Most Responsive Exercise Measurement in Idiopathic Pulmonary Fibrosis
Shinichi Arizono et al.
RESPIRATORY CARE (2014)
Physical Activity and Quality of Life Improvements of Patients With Idiopathic Pulmonary Fibrosis Completing a Pulmonary Rehabilitation Program
Ignacio A. Gaunaurd et al.
RESPIRATORY CARE (2014)
Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: A prospective cohort study
Christopher J. Ryerson et al.
RESPIRATORY MEDICINE (2014)
Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study
Magnus P. Ekstrom et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Value of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
Nizar Rifaat et al.
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS (2014)
Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial
Marius M. Hoeper et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature
Sabrina Bajwah et al.
THORAX (2013)
The benefits of exercise training in interstitial lung disease: protocol for a multicentre randomised controlled trial
Leona Dowman et al.
BMC PULMONARY MEDICINE (2013)
Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis A Randomized Trial
Maureen R. Horton et al.
ANNALS OF INTERNAL MEDICINE (2012)
Predictors of benefit following pulmonary rehabilitation for interstitial lung disease
Anne E. Holland et al.
RESPIRATORY MEDICINE (2012)
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Once-Daily Opioids for Chronic Dyspnea: A Dose Increment and Pharmacovigilance Study
David C. Currow et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2011)
Differences in Response to Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease
Ryo Kozu et al.
RESPIRATION (2011)
Benefits of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis
Jeffrey J. Swigris et al.
RESPIRATORY CARE (2011)
Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
Ryo Kozu et al.
RESPIROLOGY (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)
G. Raghu et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners
Kathleen Oare Lindell et al.
HEART & LUNG (2010)
Sildenafil Therapy and Exercise Tolerance in Idiopathic Pulmonary Fibrosis
Robert M. Jackson et al.
LUNG (2010)
A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
David A. Zisman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
Sevgi Ozalevli et al.
MULTIDISCIPLINARY RESPIRATORY MEDICINE (2010)
Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis
B. Rammaert et al.
REVUE DES MALADIES RESPIRATOIRES (2009)
BUILD-1: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
Osamu Nishiyama et al.
RESPIROLOGY (2008)
Thalidomide inhibits the intractable cough of idiopathic pulmonary fibrosis
M. R. Horton et al.
THORAX (2008)
Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease
A. E. Holland et al.
THORAX (2008)
Sildenafil improves walk distance in idiopathic pulmonary fibrosis
Harold R. Collard et al.
CHEST (2007)
Measurement of breathlessness in advanced disease: A systematic review
C. Bausewein et al.
RESPIRATORY MEDICINE (2007)
Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis
S Allen et al.
PALLIATIVE MEDICINE (2005)
A study of the cough reflex in idiopathic pulmonary fibrosis
BDM Hope-Gill et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
分享论文
